Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 0 | 296 | 0 | 0 | 0 |
| Gross Profit | N/A | 296 | N/A | N/A | N/A |
| Operating Expenses | 1,812 | 3,632 | 736 | 1,392 | 1,397 |
| Operating Income | -1,812 | -3,336 | -884 | -1,392 | -1,397 |
| Other Income | 724 | 529 | 173 | 1,476 | -58 |
| Pre-tax Income | -1,087 | -2,806 | -711 | 84 | -1,455 |
| Net Income Continuous | -1,087 | -2,806 | -711 | 84 | -1,455 |
| Net Income Discontinuous | 3,787 | 1,575 | -1,603 | -768 | -688 |
| Minority Interests | -206 | 206 | -310 | -313 | -289 |
| Net Income | $2,905 | $-1,438 | $-2,004 | $-371 | $-1,854 |
| EPS Basic Total Ops | 0.40 | -0.20 | -0.20 | -0.10 | -0.30 |
| EPS Basic Continuous Ops | -0.13 | -0.42 | 0.10 | 0.01 | -0.20 |
| EPS Basic Discontinuous Ops | 0.53 | 0.22 | -0.31 | -0.10 | -0.10 |
| EPS Diluted Total Ops | 0.37 | -0.20 | -0.20 | -0.10 | -0.30 |
| EPS Diluted Continuous Ops | -0.11 | -0.42 | 0.10 | 0.01 | -0.20 |
| EPS Diluted Discontinuous Ops | 0.48 | 0.22 | -0.31 | -0.10 | -0.10 |
| EBITDA(a) | $-1,728 | $-3,267 | $-668 | $-1,323 | $-1,430 |